Ultra Nasdaq Biotechnology Proshares (BIB) 153.74
Post# of 64074
Posted On: 02/28/2015 7:31:59 PM
Ultra Nasdaq Biotechnology Proshares (BIB) 153.74 $BIB
Biotech selling off early
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 9:04AM CST
BIB: 153.74 (-2.94), IBB: 337.47 (-3.33)
Ugly day for biotech
Seeking Alpha - at Seeking Alpha - Thu Jan 15, 1:03PM CST
BIB: 153.74 (-2.94), IBB: 337.47 (-3.33)
Biotech off to a good start on first trading day of 2015
Seeking Alpha - at Seeking Alpha - Fri Jan 02, 8:57AM CST
BIB: 153.74 (-2.94), IBB: 337.47 (-3.33)
Gilead, Abbvie, Express Scripts, And Biotech Industry Turmoil Seen By Market-Makers
Peter F. Way, CFA - Seeking Alpha - Wed Dec 24, 8:33AM CST
This is a market price forecast analysis It is not an analysis of medical technology, competition, or economics. We have limited competence in those areas. But we do have extensive experience in how market professionals have interpreted the likely...
ESRX: 84.79 (+0.25), GILD: 103.53 (-0.66), FBT: 115.23 (-0.93), BIB: 153.74 (-2.94), XBI: 214.63 (-3.26), IBB: 337.47 (-3.33), BBH: 127.98 (-1.22), ABBV: 60.50 (-0.02)
Look for Shares of ProShares Ultra Nasdaq Biotechnology ETF to Potentially Rebound after Yesterday's 9.20% Sell Off
Comtex SmarTrend(R) - Tue Dec 23, 5:13PM CST
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $116.34 to a high of $131.99. Yesterday, the shares fell 9.2%, which took the trading range below the 3-day low of $128.10 on volume of 948,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BIB: 153.74 (-2.94)
Money flowing out of biotech today
Seeking Alpha - at Seeking Alpha - Tue Dec 23, 9:40AM CST
BIS: 36.39 (+0.66), ESRX: 84.79 (+0.25), GILD: 103.53 (-0.66), BIB: 153.74 (-2.94), IBB: 337.47 (-3.33), ABBV: 60.50 (-0.02)
ProShares Ultra Nasdaq Biotechnology ETF Has Returned 22.8% Since SmarTrend Recommendation (BIB)
Comtex SmarTrend(R) - Mon Dec 15, 9:19AM CST
SmarTrend identified an Uptrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on October 21st, 2014 at $104.76. In approximately 2 months, ProShares Ultra Nasdaq Biotechnology ETF has returned 22.84% as of today's recent price of $128.68.
BIB: 153.74 (-2.94)
25.1% Return Seen to Date on SmarTrend ProShares Ultra Nasdaq Biotechnology ETF Call (BIB)
Comtex SmarTrend(R) - Fri Dec 05, 4:55PM CST
SmarTrend identified an Uptrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on October 21st, 2014 at $104.76. In approximately 2 month, ProShares Ultra Nasdaq Biotechnology ETF has returned 25.05% as of today's recent price of $131.00.
BIB: 153.74 (-2.94)
Shares of BIB Up 23.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 28, 11:03AM CST
SmarTrend identified an Uptrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on October 21st, 2014 at $104.76. In approximately 1 month, ProShares Ultra Nasdaq Biotechnology ETF has returned 23.28% as of today's recent price of $129.14.
BIB: 153.74 (-2.94)
Vargatef cleared in Europe for lung cancer
Seeking Alpha - at Seeking Alpha - Fri Nov 28, 8:23AM CST
HTBX: 6.66 (-0.16), BIB: 153.74 (-2.94), INCY: 85.85 (-1.69), PFE: 34.32 (-0.27), IBB: 337.47 (-3.33), DRGS: 58.85 (+0.05), BIND: 6.06 (-0.18), BMY: 60.92 (-0.54), GSK: 47.42 (-0.42), ONTY: 1.60 (-0.02), ECYT: 5.80 (-0.11), BIS: 36.39 (+0.66), CLVS: 76.46 (-1.43), AZN: 68.90 (-0.11), MRK: 58.54 (-0.42), ARIA: 8.13 (-0.04), IRY: 51.13 (+0.08), IXJ: 106.66 (-0.24), FPRX: 25.74 (-1.61)
UniQure sets price record with Glybera
Seeking Alpha - at Seeking Alpha - Wed Nov 26, 2:33PM CST
BIS: 36.39 (+0.66), QURE: 23.24 (+0.33), BIB: 153.74 (-2.94), ALXN: 180.37 (-2.74), IBB: 337.47 (-3.33)
China mulling eliminating drug price controls
Seeking Alpha - at Seeking Alpha - Wed Nov 26, 6:17AM CST
EWH: 21.71 (-0.03), PEK: 45.95 (-0.17), CNXT: 35.38 (+0.27), KBA: 46.58 (unch), BIB: 153.74 (-2.94), CQQQ: 35.81 (-0.28), IBB: 337.47 (-3.33), DRGS: 58.85 (+0.05), CHXF: 54.07 (+0.27), YINN: 40.58 (-0.04), FXP: 37.43 (-0.02), EWHS: 27.13 (-0.18), PGJ: 28.04 (-0.47), FCA: 23.73 (+0.10), YAO: 28.43 (-0.05), FCHI: 53.55 (-0.15), ASHR: 36.35 (-0.19), ASHS: 39.51 (unch), GXC: 82.10 (-0.20), FXI: 43.76 (-0.01), XPP: 76.05 (+0.01), KWEB: 32.43 (-0.52), ECNS: 45.05 (unch), TAO: 21.48 (-0.15), CHNA: 36.38 (-0.26), QQQC: 21.50 (-0.17), CHIX: 16.00 (unch), KFYP: 64.80 (unch), HAO: 25.89 (+0.09), MCHI: 53.06 (-0.02), CHIM: 15.39 (+0.14), YANG: 9.39 (+0.01), BIS: 36.39 (+0.66), CHIQ: 12.97 (-0.10), CHIE: 13.36 (+0.26), FHK: 41.14 (-0.14), CHII: 13.94 (-0.06), YXI: 26.75 (unch), CN: 35.33 (-0.20)
Drug makers face pushback on pricey meds
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 7:18AM CST
ABT: 47.37 (-0.24), BIIB: 409.59 (-0.51), BIB: 153.74 (-2.94), PFE: 34.32 (-0.27), AMGN: 157.72 (-1.25), IBB: 337.47 (-3.33), LLY: 70.17 (+0.14), DRGS: 58.85 (+0.05), GSK: 47.42 (-0.42), BMY: 60.92 (-0.54), CELG: 121.53 (-1.82), JNJ: 102.51 (-0.29), ESRX: 84.79 (+0.25), BIS: 36.39 (+0.66), MRK: 58.54 (-0.42), AZN: 68.90 (-0.11), CVS: 103.87 (-0.30), ABBV: 60.50 (-0.02), SNY: 48.86 (-0.01), IRY: 51.13 (+0.08), IXJ: 106.66 (-0.24), NVS: 102.40 (-0.60)
Histogenics on deck for IPO
Seeking Alpha - at Seeking Alpha - Mon Nov 24, 3:30PM CST
IPO: 24.10 (-0.16), BIS: 36.39 (+0.66), BIB: 153.74 (-2.94), IBB: 337.47 (-3.33)
CB Pharma on deck for IPO
Seeking Alpha - at Seeking Alpha - Fri Nov 21, 10:46AM CST
IPO: 24.10 (-0.16), BIS: 36.39 (+0.66), BIB: 153.74 (-2.94), CNDO: 2.57 (-0.23), IBB: 337.47 (-3.33), DRGS: 58.85 (+0.05), IXJ: 106.66 (-0.24), IRY: 51.13 (+0.08)
CF Foundation sells royalties for $3.3B
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 7:03AM CST
BIS: 36.39 (+0.66), VRTX: 119.43 (-0.54), BIB: 153.74 (-2.94), IBB: 337.47 (-3.33), DRGS: 58.85 (+0.05), IXJ: 106.66 (-0.24), IRY: 51.13 (+0.08)
Global drug tab will breach trillion dollar mark this year
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 6:41AM CST
BIS: 36.39 (+0.66), IMS: 26.32 (-0.20), PCYC: 215.93 (-1.89), GILD: 103.53 (-0.66), BIB: 153.74 (-2.94), IBB: 337.47 (-3.33), AMGN: 157.72 (-1.25), DRGS: 58.85 (+0.05), IXJ: 106.66 (-0.24), IRY: 51.13 (+0.08)
Second Sight begins trading today
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 8:42AM CST
IPO: 24.10 (-0.16), EYES: 16.17 (+4.37), BIS: 36.39 (+0.66), BIB: 153.74 (-2.94), IBB: 337.47 (-3.33)
Neothetics on deck for IPO
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 12:46PM CST
IPO: 24.10 (-0.16), BIS: 36.39 (+0.66), BIB: 153.74 (-2.94), IBB: 337.47 (-3.33)
Biotech selling off early
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 9:04AM CST
BIB: 153.74 (-2.94), IBB: 337.47 (-3.33)
Ugly day for biotech
Seeking Alpha - at Seeking Alpha - Thu Jan 15, 1:03PM CST
BIB: 153.74 (-2.94), IBB: 337.47 (-3.33)
Biotech off to a good start on first trading day of 2015
Seeking Alpha - at Seeking Alpha - Fri Jan 02, 8:57AM CST
BIB: 153.74 (-2.94), IBB: 337.47 (-3.33)
Gilead, Abbvie, Express Scripts, And Biotech Industry Turmoil Seen By Market-Makers
Peter F. Way, CFA - Seeking Alpha - Wed Dec 24, 8:33AM CST
This is a market price forecast analysis It is not an analysis of medical technology, competition, or economics. We have limited competence in those areas. But we do have extensive experience in how market professionals have interpreted the likely...
ESRX: 84.79 (+0.25), GILD: 103.53 (-0.66), FBT: 115.23 (-0.93), BIB: 153.74 (-2.94), XBI: 214.63 (-3.26), IBB: 337.47 (-3.33), BBH: 127.98 (-1.22), ABBV: 60.50 (-0.02)
Look for Shares of ProShares Ultra Nasdaq Biotechnology ETF to Potentially Rebound after Yesterday's 9.20% Sell Off
Comtex SmarTrend(R) - Tue Dec 23, 5:13PM CST
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $116.34 to a high of $131.99. Yesterday, the shares fell 9.2%, which took the trading range below the 3-day low of $128.10 on volume of 948,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BIB: 153.74 (-2.94)
Money flowing out of biotech today
Seeking Alpha - at Seeking Alpha - Tue Dec 23, 9:40AM CST
BIS: 36.39 (+0.66), ESRX: 84.79 (+0.25), GILD: 103.53 (-0.66), BIB: 153.74 (-2.94), IBB: 337.47 (-3.33), ABBV: 60.50 (-0.02)
ProShares Ultra Nasdaq Biotechnology ETF Has Returned 22.8% Since SmarTrend Recommendation (BIB)
Comtex SmarTrend(R) - Mon Dec 15, 9:19AM CST
SmarTrend identified an Uptrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on October 21st, 2014 at $104.76. In approximately 2 months, ProShares Ultra Nasdaq Biotechnology ETF has returned 22.84% as of today's recent price of $128.68.
BIB: 153.74 (-2.94)
25.1% Return Seen to Date on SmarTrend ProShares Ultra Nasdaq Biotechnology ETF Call (BIB)
Comtex SmarTrend(R) - Fri Dec 05, 4:55PM CST
SmarTrend identified an Uptrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on October 21st, 2014 at $104.76. In approximately 2 month, ProShares Ultra Nasdaq Biotechnology ETF has returned 25.05% as of today's recent price of $131.00.
BIB: 153.74 (-2.94)
Shares of BIB Up 23.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 28, 11:03AM CST
SmarTrend identified an Uptrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on October 21st, 2014 at $104.76. In approximately 1 month, ProShares Ultra Nasdaq Biotechnology ETF has returned 23.28% as of today's recent price of $129.14.
BIB: 153.74 (-2.94)
Vargatef cleared in Europe for lung cancer
Seeking Alpha - at Seeking Alpha - Fri Nov 28, 8:23AM CST
HTBX: 6.66 (-0.16), BIB: 153.74 (-2.94), INCY: 85.85 (-1.69), PFE: 34.32 (-0.27), IBB: 337.47 (-3.33), DRGS: 58.85 (+0.05), BIND: 6.06 (-0.18), BMY: 60.92 (-0.54), GSK: 47.42 (-0.42), ONTY: 1.60 (-0.02), ECYT: 5.80 (-0.11), BIS: 36.39 (+0.66), CLVS: 76.46 (-1.43), AZN: 68.90 (-0.11), MRK: 58.54 (-0.42), ARIA: 8.13 (-0.04), IRY: 51.13 (+0.08), IXJ: 106.66 (-0.24), FPRX: 25.74 (-1.61)
UniQure sets price record with Glybera
Seeking Alpha - at Seeking Alpha - Wed Nov 26, 2:33PM CST
BIS: 36.39 (+0.66), QURE: 23.24 (+0.33), BIB: 153.74 (-2.94), ALXN: 180.37 (-2.74), IBB: 337.47 (-3.33)
China mulling eliminating drug price controls
Seeking Alpha - at Seeking Alpha - Wed Nov 26, 6:17AM CST
EWH: 21.71 (-0.03), PEK: 45.95 (-0.17), CNXT: 35.38 (+0.27), KBA: 46.58 (unch), BIB: 153.74 (-2.94), CQQQ: 35.81 (-0.28), IBB: 337.47 (-3.33), DRGS: 58.85 (+0.05), CHXF: 54.07 (+0.27), YINN: 40.58 (-0.04), FXP: 37.43 (-0.02), EWHS: 27.13 (-0.18), PGJ: 28.04 (-0.47), FCA: 23.73 (+0.10), YAO: 28.43 (-0.05), FCHI: 53.55 (-0.15), ASHR: 36.35 (-0.19), ASHS: 39.51 (unch), GXC: 82.10 (-0.20), FXI: 43.76 (-0.01), XPP: 76.05 (+0.01), KWEB: 32.43 (-0.52), ECNS: 45.05 (unch), TAO: 21.48 (-0.15), CHNA: 36.38 (-0.26), QQQC: 21.50 (-0.17), CHIX: 16.00 (unch), KFYP: 64.80 (unch), HAO: 25.89 (+0.09), MCHI: 53.06 (-0.02), CHIM: 15.39 (+0.14), YANG: 9.39 (+0.01), BIS: 36.39 (+0.66), CHIQ: 12.97 (-0.10), CHIE: 13.36 (+0.26), FHK: 41.14 (-0.14), CHII: 13.94 (-0.06), YXI: 26.75 (unch), CN: 35.33 (-0.20)
Drug makers face pushback on pricey meds
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 7:18AM CST
ABT: 47.37 (-0.24), BIIB: 409.59 (-0.51), BIB: 153.74 (-2.94), PFE: 34.32 (-0.27), AMGN: 157.72 (-1.25), IBB: 337.47 (-3.33), LLY: 70.17 (+0.14), DRGS: 58.85 (+0.05), GSK: 47.42 (-0.42), BMY: 60.92 (-0.54), CELG: 121.53 (-1.82), JNJ: 102.51 (-0.29), ESRX: 84.79 (+0.25), BIS: 36.39 (+0.66), MRK: 58.54 (-0.42), AZN: 68.90 (-0.11), CVS: 103.87 (-0.30), ABBV: 60.50 (-0.02), SNY: 48.86 (-0.01), IRY: 51.13 (+0.08), IXJ: 106.66 (-0.24), NVS: 102.40 (-0.60)
Histogenics on deck for IPO
Seeking Alpha - at Seeking Alpha - Mon Nov 24, 3:30PM CST
IPO: 24.10 (-0.16), BIS: 36.39 (+0.66), BIB: 153.74 (-2.94), IBB: 337.47 (-3.33)
CB Pharma on deck for IPO
Seeking Alpha - at Seeking Alpha - Fri Nov 21, 10:46AM CST
IPO: 24.10 (-0.16), BIS: 36.39 (+0.66), BIB: 153.74 (-2.94), CNDO: 2.57 (-0.23), IBB: 337.47 (-3.33), DRGS: 58.85 (+0.05), IXJ: 106.66 (-0.24), IRY: 51.13 (+0.08)
CF Foundation sells royalties for $3.3B
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 7:03AM CST
BIS: 36.39 (+0.66), VRTX: 119.43 (-0.54), BIB: 153.74 (-2.94), IBB: 337.47 (-3.33), DRGS: 58.85 (+0.05), IXJ: 106.66 (-0.24), IRY: 51.13 (+0.08)
Global drug tab will breach trillion dollar mark this year
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 6:41AM CST
BIS: 36.39 (+0.66), IMS: 26.32 (-0.20), PCYC: 215.93 (-1.89), GILD: 103.53 (-0.66), BIB: 153.74 (-2.94), IBB: 337.47 (-3.33), AMGN: 157.72 (-1.25), DRGS: 58.85 (+0.05), IXJ: 106.66 (-0.24), IRY: 51.13 (+0.08)
Second Sight begins trading today
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 8:42AM CST
IPO: 24.10 (-0.16), EYES: 16.17 (+4.37), BIS: 36.39 (+0.66), BIB: 153.74 (-2.94), IBB: 337.47 (-3.33)
Neothetics on deck for IPO
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 12:46PM CST
IPO: 24.10 (-0.16), BIS: 36.39 (+0.66), BIB: 153.74 (-2.94), IBB: 337.47 (-3.33)
(0)
(0)Scroll down for more posts ▼